Natera

NTRA | NASDAQ | 3 Followers
$170.37 -0.87% -$1.49
Follow
Loading...

Fair Price

$67.08
Overvalued by 04.6%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Natera, Inc. (NTRA) is an American biotechnology company specializing in the development and production of non-invasive genetic tests. With advanced technologies in reproductive medicine, oncology, and transplantation, Natera provides accurate and reliable tests for prenatal screening, detection of tumor markers, and transplant monitoring. The company is known for its focus on innovation and the use of advanced bioinformatics tools, enabling it to deliver high-quality genetic testing. Natera also collaborates with medical institutions and research organizations to enhance diagnostic capabilities. Natera, Inc. (NTRA) shares could be suitable for investors looking for opportunities in the biotechnology sector with a focus on genetic testing and innovations in non-invasive diagnostics.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade